Gelonghui May 12 δΈ¨ Baicheng Pharmaceutical (301096cryptogameappsios.SZ) announcedcryptogameappsiosZhejiang Thermo Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a clinical trial approval notice from the State Drug Administration (NMPA)cryptogameappsios, the company's independently developed bios2207 drug will conduct clinical trials. BIOS2207 is indicated for the treatment of adults and children 4 years of age and older with partial seizures (with or without secondary generalized seizures).
